Stockscreener 앱 받기
9.51
0.11%
-0.010
전일 마감가:
$9.52
열려 있는:
$9.52
하루 거래량:
1.88M
Relative Volume:
0.87
시가총액:
$1.51B
수익:
$405.76M
순이익/손실:
$7.98M
주가수익비율:
190.20
EPS:
0.05
순현금흐름:
$77.47M
1주 성능:
+1.93%
1개월 성능:
+9.82%
6개월 성능:
-8.65%
1년 성능:
-19.13%
1일 변동 폭
$9.415
$9.635
1주일 범위
$9.06
$9.635
52주 변동 폭
$8.025
$15.69
Certara Inc Stock (CERT) Company Profile
명칭
Certara Inc
전화
(415) 237-8272
주소
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
CERT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
9.51 | 1.52B | 405.76M | 7.98M | 77.47M | 0.05 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-09-29 | 개시 | Craig Hallum | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-05-08 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 업그레이드 | UBS | Neutral → Buy |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2023-04-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | 개시 | Berenberg | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-01 | 개시 | Piper Sandler | Overweight |
| 2022-01-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-23 | 개시 | Robert W. Baird | Outperform |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-01-05 | 개시 | BofA Securities | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Neutral |
| 2021-01-05 | 개시 | Jefferies | Hold |
| 2021-01-05 | 개시 | William Blair | Outperform |
모두보기
Certara Inc 주식(CERT)의 최신 뉴스
Trading Systems Reacting to (CERT) Volatility - Stock Traders Daily
Buy Signal: Can Certara Inc weather a recession2025 Big Picture & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Resistance Check: Is Certara Inc being accumulated by smart moneyJuly 2025 Drop Watch & Smart Investment Allocation Insights - baoquankhu1.vn
Aug Wrap: Why Certara Inc stock remains resilientJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - Bộ Nội Vụ
Certara, Inc. (CERT) Stock Analysis: A Healthcare Innovator With 31.79% Potential Upside - DirectorsTalk Interviews
Published on: 2026-01-12 23:59:57 - Улправда
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Certara (NASDAQ:CERT) Cut to “Hold” at Wall Street Zen - Defense World
Why Certara Inc. stock remains a top recommendationWeekly Profit Recap & High Return Stock Watch Alerts - Улправда
How strong is Certara Inc. stock balance sheetJuly 2025 Action & Fast Entry High Yield Tips - Улправда
CERT: Keybanc Maintains Overweight Rating, Lowers Price Target t - GuruFocus
KeyCorp Cuts Certara (NASDAQ:CERT) Price Target to $12.00 - MarketBeat
Strong week for Certara (NASDAQ:CERT) shareholders doesn't alleviate pain of five-year loss - Yahoo Finance
Certara (NASDAQ:CERT) Raised to “Strong-Buy” at Leerink Partnrs - Defense World
Certara (NASDAQ:CERT) Upgraded at Leerink Partnrs - MarketBeat
Certara (NASDAQ:CERT) Rating Increased to Outperform at Leerink Partners - Defense World
Certara (NASDAQ:CERT) Shares Gap Up on Analyst Upgrade - Defense World
Can Certara Inc. stock surprise with earnings upside2026 world cup usa national team round of 16 goalkeepers transition play winner prediction analysis - Улправда
Leerink Partners Upgrades Certara (CERT) - Nasdaq
Certara (CERT) Upgraded by Leerink Partners with New Price Targe - GuruFocus
Certara Shares Rise After Upgrade From Leerink - marketscreener.com
Certara, Inc. (CERT) Stock Analysis: Exploring A 38.74% Potential Upside - DirectorsTalk Interviews
Certara (NASDAQ:CERT) Shares Gap Up Following Analyst Upgrade - MarketBeat
Leerink Partners upgrades Certara stock rating to Outperform By Investing.com - Investing.com Nigeria
Certara (NASDAQ:CERT) Upgraded by Leerink Partners to Outperform Rating - MarketBeat
Leerink Upgrades Certara to Outperform From Market Perform, Price Target is $13 - marketscreener.com
Leerink Partners upgrades Certara stock rating to Outperform - Investing.com
Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence - FinancialContent
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway - The Motley Fool
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway - The Motley Fool
The data fragmentation problem holding drug discovery back - marketscreener.com
How Certara Inc. (CERT) Affects Rotational Strategy Timing - Stock Traders Daily
Fort Washington Investment Advisors Inc. OH Makes New Investment in Certara, Inc. $CERT - MarketBeat
Earnings estimates moving higher for Certara (CERT): Time to buy? - MSN
Why Certara Inc. stock appeals to analystsRisk Mitigation Techniques & Free Navigate Market With Precision - bollywoodhelpline.com
Certara (NASDAQ:CERT) Releases FY 2025 Earnings Guidance - MarketBeat
Discipline and Rules-Based Execution in CERT Response - Stock Traders Daily
Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Should I hold or sell Certara Inc. stock in 2025Weekly Profit Analysis & Smart Investment Allocation Tips - Улправда
Risk Check: Why Certara Inc stock remains a top recommendationJuly 2025 Big Picture & Fast Gain Stock Tips - moha.gov.vn
Is Certara Inc. stock a buy before product launchesJuly 2025 Setups & Smart Investment Allocation Tips - Улправда
Why Certara Inc. stock is recommended by analystsGDP Growth & AI Powered Trade Plan Recommendations - Улправда
Certara (CERT): Morgan Stanley Lowers Price Target to $12.00 | C - GuruFocus
Certara (NASDAQ:CERT) Given New $12.00 Price Target at Morgan Stanley - MarketBeat
Does Certara’s (CERT) New IQVIA-Trained CEO Mark a Strategic Shift in Its Biosimulation Focus? - simplywall.st
Barclays Lowers Price Target for Certara (CERT) to $13, Maintains Overweight Rating | CERT Stock News - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Certara (CERT), Sera Prognostics (SERA) - The Globe and Mail
Certara, Inc. (NASDAQ:CERT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - 富途牛牛
Stephens Cuts Certara (NASDAQ:CERT) Price Target to $12.00 - Defense World
Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook - MSN
Certara Inc (CERT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.21%
2.88%
자본화:
|
볼륨(24시간):